This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Ewha University-Industry Collaboration Foundation, Yonsei University. Active years: 2014-2025.
Company Filing History:


Years Active: 2014-2025
Title: Yangsoo Jang: Innovator in Atherosclerosis Diagnosis and Treatment
Introduction
Yangsoo Jang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of atherosclerosis. With a total of 2 patents, his work focuses on innovative solutions that enhance patient care and treatment outcomes.
Latest Patents
Yangsoo Jang's latest patents include a marker for diagnosing atherosclerosis severity and a stent designed for protecting bifurcated blood vessels in bifurcation lesions. The first patent pertains to a marker composition that aids in diagnosing the severity of atherosclerosis. This invention includes a diagnostic kit and methods for screening substances that can prevent or treat atherosclerosis. By utilizing LGI3 expression or activity levels, this invention allows for personalized and predictive medicine approaches. The second patent involves a stent that expands the main blood vessel while ensuring smooth blood flow towards the branch blood vessel, thereby improving the accuracy of subsequent medical procedures.
Career Highlights
Throughout his career, Yangsoo Jang has worked with esteemed institutions such as Yonsei University and Ewha University-Industry Collaboration Foundation. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of Yangsoo Jang's notable coworkers include Myeong-Ki Hong and Sejin Jeon. Their collaborative efforts have further advanced the research and development of innovative medical technologies.
Conclusion
Yangsoo Jang's contributions to the field of atherosclerosis diagnosis and treatment exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced medical solutions.